Annual Drug Patent Expirations for COREG+CR
Coreg Cr is a drug marketed by Woodward and is included in one NDA. It is available from four suppliers. There are two patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for COREG CR.
The generic ingredient in COREG CR is carvedilol phosphate. Four suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
